Citation | Barlind, JG; Bauer, UA; Birch, AM; Birtles, S; Buckett, LK; Butlin, RJ; Davies, RD; Eriksson, JW; Hammond, CD; Hovland, R; Johannesson, P; Johansson, MJ; Kemmitt, PD; Lindmark, BT; Morentin Gutierrez, P; Noeske, TA; Nordin, A; O'Donnell, CJ; Petersson, AU; Redzic, A; Turnbull, AV; Vinblad, J Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem55:10610-29 (2012) [PubMed] Article |
---|
SMILES | CCc1nc(C)c(nc1C(N)=O)-c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1 |r,wU:18.19,wD:21.23,(61.37,-52.27,;62.71,-53.04,;64.04,-52.27,;65.38,-53.04,;66.71,-52.27,;68.05,-53.04,;66.71,-50.74,;65.38,-49.96,;64.04,-50.73,;62.71,-49.96,;61.38,-50.73,;62.71,-48.42,;68.04,-49.97,;69.38,-50.74,;70.71,-49.97,;70.71,-48.42,;69.37,-47.65,;68.04,-48.42,;72.04,-47.65,;72.03,-46.11,;73.37,-45.34,;74.71,-46.11,;76.04,-45.34,;77.37,-46.11,;78.71,-45.34,;77.37,-47.65,;74.7,-47.65,;73.38,-48.42,)| |